McBee Moore & Vanik, IP, LLC
Boronic derivatives of hydroxamates as anticancer agents
The present disclosure relates to boronic derivatives of hydroxamate compounds, methods for making the same, methods for use as a monotherapy or in combination with one or more other therapeutic agents, for treatment of proliferative diseases such as cancer. The present disclosure also teaches the utilization of said boronic derivatives of hydroxamates as epigenetic therapy medications with enhanced bioavailability, lower-toxicity, and longer-lasting efficacy.
Xavier University of Louisiana
A C
A61P C07F
inventional inventional
Shanchun Jiawang Qiu Shilong Guangdi
Guo Liu Zhong Zheng Wang